SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001390478-24-000006
Filing Date
2024-03-29
Accepted
2024-03-29 16:00:45
Documents
1
Effectiveness Date
2024-03-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11348
  Complete submission text file 0001390478-24-000006.txt   12828
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-509138 | Film No.: 24804076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)